ANN ARBOR, Mich., Oct. 28 /PRNewswire-FirstCall/ — Adeona
Pharmaceuticals, Inc., (AMEX:
AEN) announced today that the Company will hold its Annual
Shareholders Meeting on Tuesday, November 2, from 9 a.m. to 10
a.m., at its offices located at 3930 Varsity Drive, Ann Arbor, MI,
48108.
During the Annual Shareholder Meeting, Adeona’s Chief Executive
Officer, James S. Kuo, M.D., M.B.A., will give an update on the
Company’s activities and answer questions. Admission is open to any
Adeona shareholder of record as of September 23, 2010.
About Adeona Pharmaceuticals, Inc.
Adeona (AMEX:
AEN) is a pharmaceutical company developing new medicines for
serious central nervous systems diseases. Our primary strategy is
to license clinical-stage drug candidates that have already
demonstrated a certain level of clinical efficacy and develop them
to a valuation inflection point resulting in a significant
development and marketing collaboration. We have four drug
candidates and one medical food candidate in development. Further
information on the company is available at www.adeonapharma.com.
‘/>”/>
